Concepedia

Lee T. Schaller

LT

Statistics

Publications

11

Citations

576

H-Index

11

Active since

2001

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (United Kingdom)

Institute of Medicinal Plant Development

University of Oxford

Lee T. Schaller is an author at Research Triangle Park Foundation specializing in pharmacology, enzyme inhibition, and medicinal chemistry.

Publications per year

2001–2019

11

Publications

11

Structure−Activity Relationship Studies of Novel Benzophenones Leading to the Discovery of a Potent, Next Generation HIV Nonnucleoside Reverse Transcriptase Inhibitor

Karen R. Romines, George A. Freeman, Lee T. Schaller et al. · Journal of Medicinal Chemistry · 2005 · 169 citations

, , +17

The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral

Edward P. Garvey, Brian A. Johns, Margaret Gartland et al. · Antimicrobial Agents and Chemotherapy · 2007 · 76 citations · Full text

, , +17

Novel Benzophenones as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1

Joseph H. Chan, George A. Freeman, Jeffrey H. Tidwell et al. · Journal of Medicinal Chemistry · 2004 · 65 citations · Full text

, , +17

Antiviral Activity of GW678248, a Novel Benzophenone Nonnucleoside Reverse Transcriptase Inhibitor

Robert G. Ferris, Richard Hazen, Grace Roberts et al. · Antimicrobial Agents and Chemotherapy · 2005 · 62 citations · Full text

, , +17

Design of Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase with Improved Drug Resistance Properties. 2.

George A. Freeman, C. Webster Andrews, Andrew L. Hopkins et al. · Journal of Medicinal Chemistry · 2004 · 62 citations

, , +17

1–5 of 11